LEHI, Utah and LOUISVILLE, Ky., May 29, 2025 /PRNewswire/ — Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced it has been named a 2025–2026 Best Company to Work For by U.S. News & World Report. In addition to this national honor, U.S. News & World Report also named Waystar a Best Company to Work For in both the Health Care and Research sector and the West region.
U.S. News & World Report evaluated the 5,000 largest public companies based on employee sentiment across six key factors: pay and benefits; work-life balance and flexibility; job and company stability; physical and psychological comfort; sense of belongingness and esteem; and career opportunities and professional development. Waystar earned a place in the top 6% of companies overall, as well as within the top 25% of its industry and region.
“We’re honored to be recognized by U.S. News & World Report alongside so many respected companies,” said Matt Hawkins, Chief Executive Officer of Waystar. “This recognition reflects the culture we’ve built — one rooted in innovation, shared values, and a deep commitment to our mission to simplify healthcare payments. I’m grateful to our dedicated team members, whose passion and purpose power the mission-critical software we deliver to more than one million providers nationwide.”
The recognition adds to a growing list of accolades Waystar has received for workplace culture and team member satisfaction, including designations from Fortune’s Great Place to Work®, Becker’s Healthcare, and the Women Tech Council’s Shatter List.
About Waystar
Waystar’s mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar’s enterprise-grade platform annually processes over 6 billion healthcare payment transactions, including over $1.8 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.
Media Contact
Kristin Lee
kristin.lee@waystar.com
Investor Contact
Sandy Draper
investors@waystar.com
502-238-9511
SOURCE Waystar
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…
Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…